Current Investment Opportunities


 

Centerline Biomedical

Founded: 2014
Location: Cleveland, OH
Status: Seed

Amount Seeking: $4M

About the Company: Centerline Biomedical is developing an innovative system to navigate catheters and guide wires (and ultimately devices) in the 3D anatomy of vascular disease patients. This system will empower surgeons to perform safer, more accurate, and more efficient endovascular procedures.

Visit Company Website


Cleveland Diagnostics

Founded: 2013
Location: Cleveland, OH
Status: Series A

Amount Seeking: $5M

About the Company: Cleveland Diagnostics is developing a breakthrough technology to discover new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable

Visit Company Website


ImageIQ

Founded: 2010
Location: Cleveland, OH
Status: Seed

Amount Seeking: $5M

About the Company: Far beyond simple core lab services, ImageIQ is an ICRO (Imaging Contract Research Organization) and software developer, for customized imaging, analysis and software. 

Visit Company Website


OptoQuest

Founded: 2008
Location: Cleveland, OH
Status: Pre-Seed

Amount Seeking: $2M

About the Company: OptoQuest is the culmination of years of research and development in computational modeling and non-invasive, biomechanical measurement of the eye, and is positioned to lead the simulation-based medicine revolution in anterior segment surgery. 

Visit Company Website


Infuseon Therapeutics, Inc.

Founded: 2012
Location: Cleveland, OH
Status: Seed

Amount Seeking: $5M

About the Company: Infuseon Therapeutics, Inc. was founded in 2012 by  Cleveland Clinic for to purpose of developing  a unique therapeutic delivery device via its patented Cleveland Multiport Catheter™ system. This first-ever multiport catheter was  designed by a neurosurgeon from Cleveland Clinic's Brain Tumor and NeuroOncology Center to more effectively deliver life-saving drugs to  patients at the site of their disease.
 
Parker-Hannifin Corporation, a global leader in motion and control technologies, is collaborating with Infuseon to combine and enhance the medical design, development, and manufacturing expertise of the company.

Visit Company Website


NeuroTherapia

Founded: 2015
Location: Cleveland, OH
Status: Seed

Amount Seeking: Seeking Series A

About the Company: NeuroTherapia is a private, pre-clinical stage biotechnology company developing novel therapies that decrease the neuroinflammation which plays a critical role in a wide spectrum of diseases such as neuropathic pain and Alzheimer’s disease. NeuroTherapia has secured seed funding from the Ohio Biovalidation Fund and Alzheimer Drug Discovery Foundation.

Visit Company Website


Ion-Vac

Founded: 2012
Location: Cleveland, OH
Status: Seed

Amount Seeking: $2M

About the Company: Developing novel, wound healing technologies.

Visit Company Website


Shield Biotech

Founded: 2013
Location: Cleveland, OH
Status: Series A

Amount Seeking: Seeking Series B

About the Company: Shield Biotech is a company dedicated to developing immune prevention of adult onset cancers. Its preventive breast cancer vaccine is based on research from Cleveland Clinic’s Lerner Research Institute. Shield Biotech is conducting preclinical development to seek permission from the FDA to test the vaccine as an investigational new drug in proof-of-concept first-in-human trials.

Visit Company Website


NaviGate Cardiac Structures

Founded: 2011
Location: Cleveland, OH
Status: Series A

Amount Seeking: $10-20M

About the Company: NaviGate Cardiac Structures Inc. (NCSI) is an early-stage company focused on developing transcatheter solutions for the treatment of atrioventricular valve regurgitation. The NaviGate valved-based technology was licensed from Cleveland Clinic and further modified and developed by NCSI.

Visit Company Website


Vivere Pharma

Founded: 2015
Location: Cleveland, OH
Status: Pre-Seed

Amount Seeking: Seed investment opportunity

About the Company: Vivere Therapeutics, Inc. is a therapeutic development company focused on developing the combination of regulatory-body approved therapeutics with convection-enhanced delivery (CED) catheter technology licensed to Infuseon Therapeutics, Inc. The resulting therapeutic-device combination will constitute a novel product that has the ability to deliver effective dosages to the central nervous system.

Visit Company Website


Get In Touch With Us